Brief: Sutro Biopharma Reports First Quarter 2022 Financial Results
May 9 (Reuters) - Sutro Biopharma Inc STRO.O :
* SUTRO BIOPHARMA REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS,
BUSINESS HIGHLIGHTS, AND ANTICIPATED MILESTONES
* Q1 REVENUE $5.9 MILLION
* QTRLY LOSS PER SHARE $0.84
* Q1 EARNINGS PER SHARE VIEW $-0.76, REVENUE VIEW $10.5
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nGNX6rVcD8
Further company coverage: STRO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sutro Biopharma
See all newsBrief: Sutro Biopharma Announces First Patient Dosed In Phase 1 Trial Of STRO-006
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Sutro Biopharma Inc reports results for the quarter ended June 30 - Earnings Summary
Sutro Biopharma tumbles after missing estimates